-
Ataxia Program -
Cognitive Disorders Program -
Comprehensive Epilepsy Program -
Health Services Research Program -
Movement Disorders Program -
Multiple Sclerosis & Clinical Neuroimmunology Research Program -
NeCTO Program -
Neuromuscular Diseases & ALS Program -
Neuro-Oncology Program -
NeuroSport -
Sleep Medicine Program -
Stroke Program
Our interdisciplinary approach focuses on advancing multiple sclerosis (MS) research through clinical trials, comprehensive care, and innovative symptom management. Explore our initiatives to learn more.
Mission
Our interdisciplinary research program focuses on multiple sclerosis (MS) and related conditions of the nervous system from multiple angles, incorporating patient experiences into the research to improve outcomes and develop more personalized treatments. Inspired by our patients, our discoveries are directly brought back to the clinic to improve patient care.
Sponsors
Sponsors for our work include the National Institutes of Health (NIH), the National MS Society (NMSS), the Patient-Centered Outcomes Research Institute (PCORI), and the International Progressive MS Alliance.
Clinical trials of cutting-edge MS therapeutics
Clinical trials are key to our mission. Our center evaluates medications and other therapeutic approaches to slow and prevent MS progression, while broadening patient access to new treatments.
Comprehensive Care
An interdisciplinary approach is needed to provide the most comprehensive care for MS and other complex neuroimmunological conditions. Our center prioritizes team-based research that finds ways to enhance the delivery of the most comprehensive, patient-centered care for all people with MS and other neuroimmunological disorders.
State-of-the-art methods to track and manage symptoms
We are also nationally recognized for our commitment to the discovery of personalized treatments that target the most debilitating MS symptoms, while promoting new wellness strategies to optimize function. This work is propelled by use of innovative “in-the-wild” measurement tools and wearable technologies that fully capture the patient experience.
Our patients
Our patients are crucial contributors to the success of our research program. Through participation in our research studies, and patient-stakeholder input, our patients inspire new research ideas and make our studies possible.
Interdisciplinary collaborators
Several key collaborators also have helped to make our research projects a success. These include experts in Physical Medicine and Rehabilitation, Sleep Medicine, Psychology, Epidemiology, and Mathematics.
National organizational partners
Americas Committee for Treatment and Research in Multiple Sclerosis
National Multiple Sclerosis Society
The Consortium of Multiple Sclerosis Centers
A randomized trial to determine whether combining a commonly used medication (modafinil) and cognitive behavioral therapy is more effective than either treatment alone to treat MS fatigue, and to determine if personal traits can predict the best treatment choice (The “COMBO-MS” Trial).
Associate Professor of Neurology and Section Head
Multiple Sclerosis
